Editorial comment to activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitor.

  • Yoshihiro Wada
  • Published 2014 in
    International journal of urology : official…


Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1111/iju.12423


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.